™Your Policy Risk Impact Agent
131 chapters · 1,085 sections in this title.
18 V.S.A. ch. 091, § 4601 Definitions
2.5K chars
§ 4601. Definitions As used in this chapter: (1) “Biological product” means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenam…
18 V.S.A. ch. 091, § 4605 Alternative drug or biological product selection
5.3K chars
§ 4605. Alternative drug or biological product selection (a)(1) When a pharmacist receives a prescription for a drug that is listed either by generic name or brand name in the most recent edition of or supplement to the U.S. Department of Health and Human Services’ publication Ap…
18 V.S.A. ch. 091, § 4606 Brand certification
1.5K chars
§ 4606. Brand certification If the prescriber has determined that the generic equivalent of a drug or the interchangeable biological product for the biological product being prescribed has not been effective or with reasonable certainty is not expected to be effective in treating…
18 V.S.A. ch. 091, § 4607 Information; labeling
0.9K chars
§ 4607. Information; labeling (a) Every pharmacy in the State shall have posted a sign in a prominent place that is in clear unobstructed view that shall read: “Vermont law requires pharmacists in some cases to select a less expensive generic equivalent drug or interchangeable bi…